Cargando…

Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and airway inflammation, with a prevalence of 10.1%. Among the many causes of COPD, Smoking is the leading and another big cause is (AATD α1-antitrypsin deficiency)’ an inherited disorder. Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Onur, Seda Tural, Boyracı, Neslihan, Akyıl, Fatma Tokgöz, Sökücü, Sinem Nedime, Kara, Kaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136117/
https://www.ncbi.nlm.nih.gov/pubmed/35646586
http://dx.doi.org/10.1016/j.rmcr.2022.101667
_version_ 1784714106594394112
author Onur, Seda Tural
Boyracı, Neslihan
Akyıl, Fatma Tokgöz
Sökücü, Sinem Nedime
Kara, Kaan
author_facet Onur, Seda Tural
Boyracı, Neslihan
Akyıl, Fatma Tokgöz
Sökücü, Sinem Nedime
Kara, Kaan
author_sort Onur, Seda Tural
collection PubMed
description INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and airway inflammation, with a prevalence of 10.1%. Among the many causes of COPD, Smoking is the leading and another big cause is (AATD α1-antitrypsin deficiency)’ an inherited disorder. Prevalence of COPD patients is 1.9%. World Health Organization (WHO) advice all COPD patients’ AATD rate to be screened at least once during their life. The prevalence of AATD in the general population ranges from 1:2,000–5,000 in parts of Europe and from 1 to 5,000–10,000 in the United States and Canada. CASE 1: An 81-year-old male patient with COPD. In computed tomography (CT) of the thorax, mass in the right lower lobe and a nodule in the right upper lobe were detected. The biopsy from right bronchial entrance via fiberoptic bronchoscopy (FB) yielded squamous cell carcinoma (SCC). AAT level was 169 mg/dL (ref. range: 90–200 mg/dL). M/P lowell allele was detected in genetic analysis. CASE 2: A 45-year-old male patient with COPD. Conglomerated lymhadenomegaly in the paratracheal area was detected in CT. The biopsy from mucosal infiltrates initiating from the entrance of the right upper lobe to the anterior segment revealed SCC. His AAT level was 190 mg/dL (ref. range: 90–200 mg/dL) and the genetic analysis demonstrated M/I mutation. CASE 3: A 64-year-old male COPD patient. In thorax CT, a 24 mm diameter parenchymal nodule in the left lower lobe was detected. Transthoracic fine needle aspiration biopsy from the left lung nodule showed SCC. His AAT level was 196 mg/dL (ref. range: 90–200 mg/dL) and M/P lowell allele was detected in the genetic analysis. DISCUSSION: AAT deficiency can cause early-onset of COPD, manifested with emphysema and chronic bronchitis. It has been suggested that AATD is associated with an increased risk of many types of cancer. Although the relationship between AATD or variant carriage and LC histopathology is not clear in the literature, it was detected as squamous cell carcinoma in our cases. We infer that unmeasurable lung damage is more prevalent in heterozygous patients and we believe that sharing our results may draw more attention in this regard.
format Online
Article
Text
id pubmed-9136117
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91361172022-05-28 Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants Onur, Seda Tural Boyracı, Neslihan Akyıl, Fatma Tokgöz Sökücü, Sinem Nedime Kara, Kaan Respir Med Case Rep Case Report INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and airway inflammation, with a prevalence of 10.1%. Among the many causes of COPD, Smoking is the leading and another big cause is (AATD α1-antitrypsin deficiency)’ an inherited disorder. Prevalence of COPD patients is 1.9%. World Health Organization (WHO) advice all COPD patients’ AATD rate to be screened at least once during their life. The prevalence of AATD in the general population ranges from 1:2,000–5,000 in parts of Europe and from 1 to 5,000–10,000 in the United States and Canada. CASE 1: An 81-year-old male patient with COPD. In computed tomography (CT) of the thorax, mass in the right lower lobe and a nodule in the right upper lobe were detected. The biopsy from right bronchial entrance via fiberoptic bronchoscopy (FB) yielded squamous cell carcinoma (SCC). AAT level was 169 mg/dL (ref. range: 90–200 mg/dL). M/P lowell allele was detected in genetic analysis. CASE 2: A 45-year-old male patient with COPD. Conglomerated lymhadenomegaly in the paratracheal area was detected in CT. The biopsy from mucosal infiltrates initiating from the entrance of the right upper lobe to the anterior segment revealed SCC. His AAT level was 190 mg/dL (ref. range: 90–200 mg/dL) and the genetic analysis demonstrated M/I mutation. CASE 3: A 64-year-old male COPD patient. In thorax CT, a 24 mm diameter parenchymal nodule in the left lower lobe was detected. Transthoracic fine needle aspiration biopsy from the left lung nodule showed SCC. His AAT level was 196 mg/dL (ref. range: 90–200 mg/dL) and M/P lowell allele was detected in the genetic analysis. DISCUSSION: AAT deficiency can cause early-onset of COPD, manifested with emphysema and chronic bronchitis. It has been suggested that AATD is associated with an increased risk of many types of cancer. Although the relationship between AATD or variant carriage and LC histopathology is not clear in the literature, it was detected as squamous cell carcinoma in our cases. We infer that unmeasurable lung damage is more prevalent in heterozygous patients and we believe that sharing our results may draw more attention in this regard. Elsevier 2022-05-21 /pmc/articles/PMC9136117/ /pubmed/35646586 http://dx.doi.org/10.1016/j.rmcr.2022.101667 Text en © 2022 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Onur, Seda Tural
Boyracı, Neslihan
Akyıl, Fatma Tokgöz
Sökücü, Sinem Nedime
Kara, Kaan
Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants
title Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants
title_full Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants
title_fullStr Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants
title_full_unstemmed Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants
title_short Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants
title_sort developing lung cancer in copd: possible role of carrying alpha-1 antitrypsin deficiency variants
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136117/
https://www.ncbi.nlm.nih.gov/pubmed/35646586
http://dx.doi.org/10.1016/j.rmcr.2022.101667
work_keys_str_mv AT onursedatural developinglungcancerincopdpossibleroleofcarryingalpha1antitrypsindeficiencyvariants
AT boyracıneslihan developinglungcancerincopdpossibleroleofcarryingalpha1antitrypsindeficiencyvariants
AT akyılfatmatokgoz developinglungcancerincopdpossibleroleofcarryingalpha1antitrypsindeficiencyvariants
AT sokucusinemnedime developinglungcancerincopdpossibleroleofcarryingalpha1antitrypsindeficiencyvariants
AT karakaan developinglungcancerincopdpossibleroleofcarryingalpha1antitrypsindeficiencyvariants